Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The overall objectives of this study are to compare the efficacy, safety and tolerability of AS1402 in combination with letrozole to letrozole alone as first-line treatment in post menopausal women with locally advanced or metastatic breast cancer. The primary objective is to compare the overall tumour response rate per RECIST in postmenopausal women with metastatic or locally advanced advanced breast cancer receiving AS1402 in combination with letrozole compared to letrozole alone
Critère d'inclusion
- Locally advanced or metastatic breast cancer